{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T15:27:02Z","timestamp":1771169222842,"version":"3.50.1"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cca.2019.11.010","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T10:54:57Z","timestamp":1574506497000},"page":"186-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Nutritional vitamin D in CKD: Should we measure? Should we treat?"],"prefix":"10.1016","volume":"501","author":[{"given":"Irene","family":"Capelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cianciolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Gasperoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Galassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-6252","authenticated-orcid":false,"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7150\/ijbs.3886","article-title":"Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease","volume":"8","author":"Hu","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0010","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J Med."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0020","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jim-2015-000032","article-title":"Evaluation of responses to vitamin D3 (cholecalciferol) in patients on dialysis: a systematic review and meta-analysis","volume":"64","author":"Xu","year":"2016","journal-title":"J. Investig. Med."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0025","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2215\/CJN.12581018","article-title":"Vitamin D and cardiovascular complications of CKD: what's next?","volume":"14","author":"Banerjee","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2215\/CJN.04040411","article-title":"Vitamin D therapy in chronic kidney disease and end stage renal disease","volume":"7","author":"Melamed","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.cca.2019.11.010_b0035","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/nep.13569","article-title":"Insight into the impact of vitamin D on cardiovascular outcomes in chronic kidney disease","volume":"24","author":"Junarta","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.cca.2019.11.010_b0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpp.2017.11.005","article-title":"Vitamin D's role in health and disease: how does the present inform our understanding of the past?","volume":"23","author":"Lockau","year":"2018","journal-title":"Int. J. Paleopathol."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/nu5010111","article-title":"Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation","volume":"5","author":"Wacker","year":"2013","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2012.03.003","article-title":"Vitamin D: metabolism","volume":"38","author":"Christakos","year":"2012","journal-title":"Rheum Dis. Clin. North Am."},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0055","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.05781207","article-title":"Hypovitaminosis D in chronic kidney disease","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0065","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3109\/0886022X.2015.1043920","article-title":"Vitamin D supplements in chronic kidney disease","volume":"37","author":"Zhu","year":"2015","journal-title":"Ren. Fail"},{"key":"10.1016\/j.cca.2019.11.010_b0070","unstructured":"K.D.I.G.O.K.C.-M.W. Group, KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), Kidney Int Suppl (113) (2009) S1-130."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nefro.2018.07.004","article-title":"Native vitamin D in pre-dialysis chronic kidney disease","volume":"39","author":"Cardoso","year":"2019","journal-title":"Nefrologia"},{"key":"10.1016\/j.cca.2019.11.010_b0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cca.2014.01.026","article-title":"Evaluation of automated immunoassays for 25(OH)-vitamin D determination in different critical populations before and after standardization of the assays","volume":"431","author":"Cavalier","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0085","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12020-017-1369-3","article-title":"Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion","volume":"59","author":"Giannini","year":"2018","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/j.cca.2019.11.010_b0090","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40618-014-0190-6","article-title":"Toward a physiological referent for the vitamin D requirement","volume":"37","author":"Heaney","year":"2014","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1017\/S0007114517000538","article-title":"Common genetic variants are associated with lower serum 25-hydroxyvitamin D concentrations across the year among children at northern latitudes","volume":"117","author":"Petersen","year":"2017","journal-title":"Br. J. Nutr."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0100","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1053\/j.ajkd.2018.06.031","article-title":"The role of vitamin D in CKD stages 3 to 4: report of a scientific workshop sponsored by the national kidney foundation","volume":"72","author":"Melamed","year":"2018","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semnephrol.2013.07.006","article-title":"Fibroblast growth factor 23, vitamin D, and health disparities among African Americans with chronic kidney disease","volume":"33","author":"Saxena","year":"2013","journal-title":"Semin. Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.07020711","article-title":"Racial differences in markers of mineral metabolism in advanced chronic kidney disease","volume":"7","author":"Jovanovich","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.11.010_b0115","unstructured":"Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21796828., Washington, DC: The National Academies Press2011."},{"issue":"7","key":"10.1016\/j.cca.2019.11.010_b0120","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40618-016-0553-2","article-title":"How the reference values for serum parathyroid hormone concentration are (or should be) established?","volume":"40","author":"Souberbielle","year":"2017","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF03345365","article-title":"There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase","volume":"28","author":"Vieth","year":"2005","journal-title":"J. Endocrinol. Invest."},{"issue":"4 Suppl 3","key":"10.1016\/j.cca.2019.11.010_b0135","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"Foundation","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0140","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease'","volume":"84","author":"Andrassy","year":"2013","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.cca.2019.11.010_b0145","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/ndt\/gfq513","article-title":"Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement","volume":"25","author":"Goldsmith","year":"2010","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.cca.2019.11.010_b0150","doi-asserted-by":"crossref","unstructured":"K.D.I.G.O.K.C.-M.U.W. Group, KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and BoneDisorder (CKD-MBD), Kidney Int Suppl (2011) 7(1) (2017) 1-59.","DOI":"10.1016\/j.kisu.2017.04.001"},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40620-015-0186-0","article-title":"Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low","volume":"29","author":"Ennis","year":"2016","journal-title":"J. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40620-016-0305-6","article-title":"Vitamin D in patients with chronic kidney disease: a position statement of the working group \u201ctrace elements and mineral metabolism\u201d of the Italian society of nephrology","volume":"29","author":"Morrone","year":"2016","journal-title":"J. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0170","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clnu.2017.04.020","article-title":"Serum 24,25-dihydroxyvitamin D","volume":"37","author":"Graeff-Armas","year":"2018","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0175","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1373\/clinchem.2014.222521","article-title":"Vitamin D: the more we know, the less we know","volume":"61","author":"Scott","year":"2015","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195427","article-title":"Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3","volume":"13","author":"K\u00e4gi","year":"2018","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.cca.2019.11.010_b0185","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2215\/CJN.00530117","article-title":"Effects of vitamin D","volume":"12","author":"Batacchi","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.cca.2019.11.010_b0190","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ki.2012.270","article-title":"Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)","volume":"82","author":"Dr\u00fceke","year":"2012","journal-title":"Kidney Int."},{"issue":"4 Suppl 4","key":"10.1016\/j.cca.2019.11.010_b0195","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","article-title":"Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the kidney early evaluation program (KEEP)","volume":"53","author":"Bhuriya","year":"2009","journal-title":"Am. J. Kidney Dis."},{"issue":"11","key":"10.1016\/j.cca.2019.11.010_b0200","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.cca.2019.11.010_b0205","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000495138","article-title":"Active vitamin D in chronic kidney disease: getting right back where we started from?","volume":"5","author":"Negrea","year":"2019","journal-title":"Kidney Dis. (Basel)"},{"issue":"10","key":"10.1016\/j.cca.2019.11.010_b0215","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/17512433.2017.1371011","article-title":"Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease","volume":"10","author":"Galassi","year":"2017","journal-title":"Exp. Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.cca.2019.11.010_b0225","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in medical inpatients","volume":"338","author":"Thomas","year":"1998","journal-title":"N Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0230","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ecl.2010.02.016","article-title":"Vitamin D: extraskeletal health","volume":"39","author":"Holick","year":"2010","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0235","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","article-title":"Plasma 25-hydroxyvitamin D levels and risk of incident hypertension","volume":"49","author":"Forman","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0240","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCOUTCOMES.112.967604","article-title":"Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies","volume":"5","author":"Wang","year":"2012","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0245","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.20875","article-title":"Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization","volume":"99","author":"van Driel","year":"2006","journal-title":"J. Cell Biochem."},{"issue":"1\u20132","key":"10.1016\/j.cca.2019.11.010_b0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2011.05.024","article-title":"Vitamin D metabolism within bone cells: effects on bone structure and strength","volume":"347","author":"Anderson","year":"2011","journal-title":"Mol Cell Endocrinol."},{"issue":"10","key":"10.1016\/j.cca.2019.11.010_b0255","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/en.2010-0334","article-title":"Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption","volume":"151","author":"Kogawa","year":"2010","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0260","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ndt\/gfw082","article-title":"Pro: Should we correct vitamin D deficiency\/insufficiency in chronic kidney disease patients with inactive forms of vitamin D or just treat them with active vitamin D forms?","volume":"31","author":"Goldsmith","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0265","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ndt\/gfw081","article-title":"Moderator's view: vitamin D deficiency treatment in advanced chronic kidney disease: a close look at the emperor's clothes","volume":"31","author":"Zoccali","year":"2016","journal-title":"Nephrol. Dial Transplant."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0270","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/gfw080","article-title":"Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease","volume":"31","author":"Agarwal","year":"2016","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.cca.2019.11.010_b0275","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/864012","article-title":"Which vitamin D in CKD-MBD? The time of burning questions","volume":"2013","author":"Galassi","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0280","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1681\/ASN.2016010066","article-title":"Fibroblast growth factor 23 regulation by systemic and local osteoblast-synthesized 1,25-dihydroxyvitamin D","volume":"28","author":"Nguyen-Yamamoto","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"15","key":"10.1016\/j.cca.2019.11.010_b0285","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0290","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Dr\u00fceke","year":"2016","journal-title":"Kidney Int."},{"issue":"13","key":"10.1016\/j.cca.2019.11.010_b0295","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126467","article-title":"Vitamin D-regulated osteocytic sclerostin and BMP2 modulate uremic extraskeletal calcification","volume":"4","author":"Nguyen-Yamamoto","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1570161115666170310092202","article-title":"Klotho-FGF23, cardiovascular disease, and vascular calcification: black or white?","volume":"16","author":"Cianciolo","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0305","first-page":"2967","article-title":"25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands","volume":"87","author":"Segersten","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0310","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.ki.5000394","article-title":"25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells","volume":"70","author":"Ritter","year":"2006","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0315","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0320","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000157177","article-title":"Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease","volume":"31","author":"Oksa","year":"2008","journal-title":"Kidney Blood Press. Res."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0325","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","article-title":"Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study","volume":"14","author":"Chandra","year":"2008","journal-title":"Endocr. Pract."},{"issue":"9","key":"10.1016\/j.cca.2019.11.010_b0330","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/ndt\/gfs138","article-title":"Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D","volume":"27","author":"Marckmann","year":"2012","journal-title":"Nephrol. Dial Transplant."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0335","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.07131009","article-title":"A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease","volume":"5","author":"Moe","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0340","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ndt\/gft360","article-title":"The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study","volume":"29","author":"Molina","year":"2014","journal-title":"Nephrol. Dial Transplant."},{"issue":"7","key":"10.1016\/j.cca.2019.11.010_b0345","first-page":"643","article-title":"Efficacy of high vs. conventional ergocalciferol dose for increasing 25-hydroxyvitamin D and suppressing parathyroid hormone levels in stage III-IV CKD with vitamin D deficiency\/insufficiency: a randomized controlled trial","volume":"98","author":"Thimachai","year":"2015","journal-title":"J. Med. Assoc. Thai"},{"key":"10.1016\/j.cca.2019.11.010_b0350","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/IJNRD.S90968","article-title":"Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report","volume":"8","author":"Cupisti","year":"2015","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0355","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfx059","article-title":"High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3\u20134: results of a 12-week double-blind, randomized, controlled study","volume":"33","author":"Westerberg","year":"2018","journal-title":"Nephrol. Dial Transplant."},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0360","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000499187","article-title":"Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease","volume":"49","author":"Strugnell","year":"2019","journal-title":"Am. J. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0365","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3945\/ajcn.112.040642","article-title":"V. Tangpricha, High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial","volume":"96","author":"Alvarez","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0370","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2011.06.027","article-title":"Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial","volume":"59","author":"Kovesdy","year":"2012","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"10.1016\/j.cca.2019.11.010_b0375","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1017\/S000711451600427X","article-title":"Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial","volume":"116","author":"Wetmore","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.cca.2019.11.010_b0380","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2016.07.019","article-title":"Ergocalciferol versus calcitriol for controlling chronic kidney disease mineral bone disorder in stage 3 to 5 CKD: a randomized controlled trial","volume":"789","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0385","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2215\/CJN.06910714","article-title":"Nutritional vitamin D supplementation in dialysis: a randomized trial","volume":"10","author":"Bhan","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0390","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000446863","article-title":"Vitamin D in kidney transplant recipients: mechanisms and therapy","volume":"43","author":"Cianciolo","year":"2016","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0395","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/TP.0b013e3181c6910f","article-title":"Potential nonclassical effects of vitamin D in transplant recipients","volume":"89","author":"Courbebaisse","year":"2010","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0400","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.ajkd.2012.07.022","article-title":"CKD-mineral and bone disorder management in kidney transplant recipients","volume":"61","author":"Alshayeb","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0405","first-page":"190","article-title":"The fate of bone after renal transplantation","volume":"17","author":"Brandenburg","year":"2004","journal-title":"J. Nephrol."},{"issue":"10","key":"10.1016\/j.cca.2019.11.010_b0410","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.transproceed.2007.10.001","article-title":"Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients","volume":"39","author":"Lehmann","year":"2007","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.cca.2019.11.010_b0415","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/j.1600-6143.2007.01950.x","article-title":"Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"7","author":"Borchhardt","year":"2007","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0420","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/TP.0b013e3182985468","article-title":"Persistence of bone and mineral disorders 2 years after successful kidney transplantation","volume":"96","author":"Neves","year":"2013","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0425","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40265-019-01074-4","article-title":"Management of post-transplant hyperparathyroidism and bone disease","volume":"79","author":"Delos Santos","year":"2019","journal-title":"Drugs"},{"issue":"23","key":"10.1016\/j.cca.2019.11.010_b0430","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0435","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/ajkd.2000.8289","article-title":"Bone disease in patients with long-term renal transplantation and normal renal function","volume":"36","author":"Carlini","year":"2000","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.cca.2019.11.010_b0440","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0445","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/TP.0000000000000583","article-title":"Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism","volume":"99","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0450","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.TP.0000149322.70295.A5","article-title":"A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids","volume":"79","author":"Wissing","year":"2005","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0455","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ki.2008.549","article-title":"Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients","volume":"75","author":"Courbebaisse","year":"2009","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.cca.2019.11.010_b0460","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1080\/08860220802406369","article-title":"The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study","volume":"30","author":"Sahin","year":"2008","journal-title":"Ren. Fail"},{"key":"10.1016\/j.cca.2019.11.010_b0465","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/1745-6215-15-430","volume":"15","author":"Courbebaisse","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.cca.2019.11.010_b0470","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1745-6215-10-36","article-title":"VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome","volume":"10","author":"Thiem","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.cca.2019.11.010_b0475","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2019-00194","article-title":"Vitamin D and atherosclerotic cardiovascular disease","author":"Hiemstra","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0480","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1172\/JCI113010","article-title":"Vitamin D3 and cardiovascular function in rats","volume":"79","author":"Weishaar","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"1 Pt 1","key":"10.1016\/j.cca.2019.11.010_b0485","article-title":"Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties","volume":"258","author":"Weishaar","year":"1990","journal-title":"Am. J. Physiol."},{"issue":"17","key":"10.1016\/j.cca.2019.11.010_b0490","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.111.032680","article-title":"Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0495","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jsha.2015.02.003","article-title":"Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome: still a myth or a fact that needs exploration?","volume":"27","author":"Fanari","year":"2015","journal-title":"J. Saudi Heart Assoc."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0500","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/hrt.2007.126359","article-title":"Vitamin D and calcium dyshomoeostasis-associated heart failure","volume":"94","author":"Weber","year":"2008","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0505","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD\u2013the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0510","doi-asserted-by":"crossref","DOI":"10.3390\/nu10060709","article-title":"Impact of vitamin D on the cardiovascular system in advanced chronic kidney disease (CKD) and dialysis patients","volume":"10","author":"Gluba-Brz\u00f3zka","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0515","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","article-title":"Vascular calcification in chronic kidney disease: different bricks in the wall?","volume":"91","author":"Vervloet","year":"2017","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.cca.2019.11.010_b0520","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/14779072.2019.1637255","article-title":"Vitamin D status, gender and cardiovascular diseases: a systematic review of prospective epidemiological studies","volume":"17","author":"Kouvari","year":"2019","journal-title":"Exp. Rev. Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0525","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.abb.2011.11.003","article-title":"25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D","volume":"523","author":"Jones","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0530","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1172\/JCI106823","article-title":"Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium, and calcium","volume":"51","author":"Puschett","year":"1972","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0535","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1185\/03007995.2013.766162","article-title":"Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)","volume":"29","author":"Rizzoli","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"issue":"10","key":"10.1016\/j.cca.2019.11.010_b0540","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2337\/db08-0593","article-title":"Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the medical research council ely prospective study 1990\u20132000","volume":"57","author":"Forouhi","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0545","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2008.560","article-title":"Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third national health and nutrition examination survey","volume":"169","author":"Ginde","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0550","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3945\/ajcn.112.047712","article-title":"Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study","volume":"97","author":"Sch\u00f6ttker","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.cca.2019.11.010_b0555","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.2008111157","article-title":"25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification","volume":"20","author":"de Boer","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0560","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MJT.0b013e3182211b3b","article-title":"Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events","volume":"20","author":"Lishmanov","year":"2013","journal-title":"Am. J. Ther."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091363","article-title":"Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients","volume":"9","author":"Chitalia","year":"2014","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.cca.2019.11.010_b0570","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1681\/ASN.2017010003","article-title":"A randomized trial of vitamin D supplementation on vascular function in CKD","volume":"28","author":"Kumar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.cca.2019.11.010_b0575","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10791016","article-title":"Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD","volume":"12","author":"Levin","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.cca.2019.11.010_b0580","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008273","article-title":"Effect of vitamin D supplementation on markers of vascular function: a systematic review and individual participant meta-analysis","volume":"7","author":"Beveridge","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"22","key":"10.1016\/j.cca.2019.11.010_b0585","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.jacc.2016.03.508","article-title":"Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study","volume":"67","author":"Witte","year":"2016","journal-title":"J. Am. Coll Cardiol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0590","doi-asserted-by":"crossref","first-page":"e88767","DOI":"10.1371\/journal.pone.0088767","article-title":"Vitamin D deficiency and exogenous vitamin D excess similarly increase diffuse atherosclerotic calcification in apolipoprotein E knockout mice","volume":"9","author":"Ellam","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050652","article-title":"Vitamin D in vascular calcification: a double-edged sword?","volume":"10","author":"Wang","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2019.11.010_b0600","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fmed.2018.00282","article-title":"Vitamin D deficiency aggravates the renal features of moderate chronic kidney disease in 5\/6 nephrectomized rats","volume":"5","author":"de Bragan\u00e7a","year":"2018","journal-title":"Front Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0605","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MNH.0b013e32834de4ee","article-title":"Vitamin D: roles in renal and cardiovascular protection","volume":"21","author":"Li","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0610","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1043-2760(03)00111-5","article-title":"The intrarenal renin-angiotensin system and diabetic nephropathy","volume":"14","author":"Carey","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0615","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"41","key":"10.1016\/j.cca.2019.11.010_b0620","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0625","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1523-1755.2001.059002415.x","article-title":"Transcription factor-kappa B (NF-kappa B) and renal disease","volume":"59","author":"Guijarro","year":"2001","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0630","doi-asserted-by":"crossref","first-page":"E315","DOI":"10.1152\/ajpendo.00590.2005","article-title":"Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor","volume":"291","author":"Sun","year":"2006","journal-title":"Am. J Physiol. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.cca.2019.11.010_b0635","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/ki.2008.453","article-title":"Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation","volume":"74","author":"Zehnder","year":"2008","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.cca.2019.11.010_b0640","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1681\/ASN.2009010019","article-title":"Wnt\/beta-catenin signaling promotes podocyte dysfunction and albuminuria","volume":"20","author":"Dai","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2019.11.010_b0645","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.molcel.2006.01.037","article-title":"The molecular basis of vitamin D receptor and beta-catenin crossregulation","volume":"21","author":"Shah","year":"2006","journal-title":"Mol Cell"},{"issue":"41","key":"10.1016\/j.cca.2019.11.010_b0650","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1073\/pnas.0803751105","article-title":"Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0655","doi-asserted-by":"crossref","first-page":"F791","DOI":"10.1152\/ajprenal.00247.2009","article-title":"Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist","volume":"297","author":"Zhang","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0660","doi-asserted-by":"crossref","first-page":"F1573","DOI":"10.1152\/ajprenal.00423.2006","article-title":"Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin","volume":"292","author":"Takano","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"37","key":"10.1016\/j.cca.2019.11.010_b0665","doi-asserted-by":"crossref","first-page":"32011","DOI":"10.1074\/jbc.M111.269118","article-title":"Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression","volume":"286","author":"Deb","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cca.2019.11.010_b0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107228","article-title":"Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury","volume":"9","author":"Gon\u00e7alves","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0675","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.semnephrol.2009.01.004","article-title":"Role of vitamin D in chronic kidney disease","volume":"29","author":"Patel","year":"2009","journal-title":"Semin. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0680","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.cca.2019.11.010_b0685","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.2011.224","article-title":"Oral cholecalciferol decreases albuminuria and urinary TGF-\u03b21 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition","volume":"80","author":"Kim","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.11.010_b0690","doi-asserted-by":"crossref","unstructured":"C.A. Keyzer, I.J. Riphagen, M.M. Joosten, G. Navis, A.C. Muller Kobold, I.P. Kema, S.J. Bakker, M.H. de Borst, N. consortium, Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients, J Clin Endocrinol Metab 100(1) (2015) 81-9.","DOI":"10.1210\/jc.2014-3012"},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0695","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1681\/ASN.2012060614","article-title":"Vitamin D status and outcomes after renal transplantation","volume":"24","author":"Bienaim\u00e9","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0700","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2013-2421","article-title":"Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study","volume":"99","author":"Obi","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.11.010_b0705","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.trim.2016.11.003","article-title":"Clinical effects of pre-transplant serum 25-hydroxyvitamin D level on post-transplant immunologic and non-immunologic outcomes in kidney transplant recipients","volume":"40","author":"Ban","year":"2017","journal-title":"Transpl. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0710","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/TP.0000000000000055","article-title":"Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients","volume":"98","author":"Lee","year":"2014","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.cca.2019.11.010_b0715","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1681\/ASN.2008091005","article-title":"Significance and management of proteinuria in kidney transplant recipients","volume":"20","author":"Amer","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.cca.2019.11.010_b0720","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2215\/CJN.01310211","article-title":"Posttransplantation proteinuria: an approach to diagnosis and management","volume":"6","author":"Shamseddin","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0725","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/TP.0b013e318200ba37","article-title":"Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study","volume":"91","author":"Courbebaisse","year":"2011","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1016\/j.cca.2019.11.010_b0730","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfs508","article-title":"Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation?","volume":"27","author":"Marc\u00e9n","year":"2012","journal-title":"Nephrol. Dial Transplant."},{"issue":"5","key":"10.1016\/j.cca.2019.11.010_b0735","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000362492","article-title":"Importance of vascular calcification in kidney transplant recipients","volume":"39","author":"Cianciolo","year":"2014","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0740","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000430813","article-title":"Ergocalciferol versus cholecalciferol for nutritional vitamin D replacement in CKD","volume":"130","author":"Mangoo-Karim","year":"2015","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.cca.2019.11.010_b0745","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000450766","article-title":"Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"44","author":"Sprague","year":"2016","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2019.11.010_b0750","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/hdi.12209","article-title":"Weekly high-dose ergocalciferol to correct vitamin D deficiency\/insufficiency in hemodialysis patients: a pilot trial","volume":"19","author":"Del Valle","year":"2015","journal-title":"Hemodial. Int."},{"issue":"7","key":"10.1016\/j.cca.2019.11.010_b0755","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/ndt\/gft001","article-title":"Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study","volume":"28","author":"Delanaye","year":"2013","journal-title":"Nephrol. Dial Transplant."},{"issue":"2","key":"10.1016\/j.cca.2019.11.010_b0760","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3945\/ajcn.111.025502","article-title":"Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis","volume":"95","author":"Wasse","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.cca.2019.11.010_b0765","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2215\/CJN.12761211","article-title":"25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis","volume":"7","author":"Armas","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2019.11.010_b0770","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/147323001103900345","article-title":"High-dose cholecalciferol supplementation for vitamin D deficiency in haemodialysis patients","volume":"39","author":"Jakopin","year":"2011","journal-title":"J. Int. Med. Res."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119321230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119321230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:52:19Z","timestamp":1757861539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119321230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":154,"alternative-id":["S0009898119321230"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.11.010","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional vitamin D in CKD: Should we measure? Should we treat?","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}